Aflibercept in persistent neovascular AMD: comparison of different treatment strategies in switching therapy – (Eye Journal AOP)
Aflibercept in persistent neovascular AMD: comparison of different treatment strategies in switching therapy Eye advance online publication, October 7 2016. doi:10.1038/eye.2016.214 Authors: D Călugăru & M Călugăru
Aflibercept in persistent neovascular AMD: comparison of different treatment strategies in switching therapy – (Eye Journal AOP)
Aflibercept in persistent neovascular AMD: comparison of different treatment strategies in switching therapy Eye advance online publication, October 7 2016. doi:10.1038/eye.2016.215 Authors: F Ricci, M Parravano, F Regine, M Sciamanna, M Tedeschi, F Missiroli & M Varano
Structural and molecular changes in the aging choroid: implications for age-related macular degeneration – (Eye Journal AOP)
Structural and molecular changes in the aging choroid: implications for age-related macular degeneration Eye advance online publication, October 7 2016. doi:10.1038/eye.2016.216 Authors: K R Chirco, E H Sohn, E M Stone, B A Tucker & R F Mullins
Risk of geographic atrophy in age-related macular degeneration patients treated with intravitreal anti-VEGF agents – (Eye Journal AOP)
Risk of geographic atrophy in age-related macular degeneration patients treated with intravitreal anti-VEGF agents Eye advance online publication, October 7 2016. doi:10.1038/eye.2016.208 Authors: M Gemenetzi, A J Lotery & P J Patel
Reply to ‘Can photoreceptor loss also account for changes in pupil size following panretinal photocoagulation?’ – (Eye Journal AOP)
Reply to ‘Can photoreceptor loss also account for changes in pupil size following panretinal photocoagulation?’ Eye advance online publication, October 7 2016. doi:10.1038/eye.2016.211 Authors: I Yilmaz & A Ozkaya